CARDIFF ONCOLOGY, INC. Amortization of Deferred Leasing Fees
CARDIFF ONCOLOGY, INC. (CRDF) reported Amortization of Deferred Leasing Fees of -$136.78 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredLeasingFees · last filed 2017-08-09
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for the quarter ending 2017-06-30 was -$70.66K.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for the quarter ending 2017-03-31 was -$66.12K.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for the quarter ending 2016-12-31 was -$67.66K.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for the quarter ending 2016-09-30 was -$66.69K.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for fiscal 2016 was -$201.04K.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for fiscal 2015 was $0.00.
- CARDIFF ONCOLOGY, INC. amortization of deferred leasing fees for fiscal 2014 was $0.00.
| Period end | Amortization of Deferred Leasing Fees 3 month | Amortization of Deferred Leasing Fees 6 month | Amortization of Deferred Leasing Fees 9 month | Amortization of Deferred Leasing Fees 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$70.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$136.78K 10-Q · filed 2017-08-09 | -$204.44K derived: sum of 3 quarters · filed 2017-08-09 | -$271.12K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | -$66.12K 10-Q · filed 2017-05-10 | -$133.78K derived: sum of 2 quarters · filed 2017-05-10 | -$200.47K derived: sum of 3 quarters · filed 2017-05-10 | -$267.16K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-12-31 | -$67.66K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$134.35K derived: sum of 2 quarters · filed 2017-03-15 | -$201.04K derived: sum of 3 quarters · filed 2017-08-09 | -$201.04K 10-K · filed 2017-03-15 |
| 2016-09-30 | -$66.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$133.38K derived: sum of 2 quarters · filed 2017-08-09 | -$133.38K 10-Q · filed 2016-11-09 | -$133.38K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | -$66.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$66.69K 10-Q · filed 2017-08-09 | -$66.69K derived: sum of 3 quarters · filed 2017-08-09 | -$66.69K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |